» Articles » PMID: 21663988

Comparison of Intensity-modulated Radiotherapy, Adaptive Radiotherapy, Proton Radiotherapy, and Adaptive Proton Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2011 Jun 14
PMID 21663988
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Various radiotherapy planning methods for locally advanced squamous cell carcinoma of the head and neck (SCCHN) have been proposed to decrease normal tissue toxicity. We compare IMRT, adaptive IMRT, proton therapy (IMPT), and adaptive IMPT for SCCHN.

Materials And Methods: Initial and re-simulation CT images from 10 consecutive patients with SCCHN were used to quantify dosimetric differences between photon and proton therapy. Contouring was performed on both CTs, and plans (n=40 plans) and dose-volume histograms were generated.

Results: The mean GTV volume decreased 53.4% with re-simulation. All plans provided comparable PTV coverage. Compared with IMRT, adaptive IMRT significantly reduced the maximum dose to the mandible (p=0.020) and mean doses to the contralateral parotid gland (p=0.049) and larynx (p=0.049). Compared with IMRT and adaptive IMRT, IMPT significantly lowered the maximum doses to the spinal cord (p<0.002 for both) and brainstem (p<0.002 for both) and mean doses to the larynx (p<0.002 for both) and ipsilateral (p=0.004 IMRT, p=0.050 adaptive) and contralateral (p<0.002 IMRT, p=0.010 adaptive) parotid glands. Adaptive IMPT significantly reduced doses to all critical structures compared with IMRT and adaptive IMRT and several critical structures compared with non-adaptive IMPT.

Conclusions: Although adaptive IMRT reduced dose to several normal structures compared with standard IMRT, non-adaptive proton therapy had a more favorable dosimetric profile than IMRT or adaptive IMRT and may obviate the need for adaptive planning. Protons allowed significant sparing of the spinal cord, parotid glands, larynx, and brainstem and should be considered for SCCHN to decrease normal tissue toxicity while still providing optimal tumor coverage.

Citing Articles

Salivary Gland Volume Changes and Dry Mouth Symptom Following Definitive Radiation Therapy in Oropharyngeal Cancer Patients-A Comparison of Two Different Approaches: Intensity-Modulated Radiation Therapy Versus Intensity-Modulated Radiation....

Park S, Ahn Y, Oh D, Yang K, Ju S, Kim J Cancers (Basel). 2025; 17(3).

PMID: 39941919 PMC: 11816663. DOI: 10.3390/cancers17030554.


Accuracy Evaluation of Dose Warping Using Deformable Image Registration in Carbon Ion Therapy.

Miyasaka Y, Souda H, Chai H, Ishizawa M, Sato H, Iwai T Int J Part Ther. 2025; 15():100639.

PMID: 39835280 PMC: 11743904. DOI: 10.1016/j.ijpt.2024.100639.


A retrospective study on the investigation of potential dosimetric benefits of online adaptive proton therapy for head and neck cancer.

Chang C, Bohannon D, Tian Z, Wang Y, McDonald M, Yu D J Appl Clin Med Phys. 2024; 25(5):e14308.

PMID: 38368614 PMC: 11087169. DOI: 10.1002/acm2.14308.


Cone beam CT-based adaptive intensity modulated proton therapy assessment using automated planning for head-and-neck cancer.

Xu Y, Jin W, Butkus M, De Ornelas M, Cyriac J, Studenski M Radiat Oncol. 2024; 19(1):13.

PMID: 38263237 PMC: 10804468. DOI: 10.1186/s13014-024-02406-9.


Advances in radiation therapy for testicular seminoma.

Rosen D, Tan A, Pursley J, Kamran S World J Urol. 2023; 41(12):3895-3903.

PMID: 37979002 DOI: 10.1007/s00345-023-04674-8.


References
1.
Corvo R . Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol. 2007; 85(1):156-70. DOI: 10.1016/j.radonc.2007.04.002. View

2.
Wu Q, Chi Y, Chen P, Krauss D, Yan D, Martinez A . Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009; 75(3):924-32. DOI: 10.1016/j.ijrobp.2009.04.047. View

3.
Salama J, Haddad R, Kies M, Busse P, Dong L, Brizel D . Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; 75(3):725-33. DOI: 10.1016/j.ijrobp.2008.11.059. View

4.
Johansson J, Blomquist E, Montelius A, Isacsson U, Glimelius B . Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol. 2004; 72(2):129-38. DOI: 10.1016/j.radonc.2004.03.018. View

5.
Castadot P, Geets X, Lee J, Christian N, Gregoire V . Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol. 2010; 95(2):209-17. DOI: 10.1016/j.radonc.2010.03.007. View